Pulmonary hypertension

A Mocumbi, M Humbert, A Saxena, ZC Jing… - Nature Reviews …, 2024 - nature.com
Pulmonary hypertension encompasses a range of conditions directly or indirectly leading to
elevated pressures within the pulmonary arteries. Five main groups of pulmonary …

Assessment of right ventricular function in the research setting: knowledge gaps and pathways forward. An Official American Thoracic Society Research Statement

T Lahm, IS Douglas, SL Archer, HJ Bogaard… - American journal of …, 2018 - atsjournals.org
Background: Right ventricular (RV) adaptation to acute and chronic pulmonary hypertensive
syndromes is a significant determinant of short-and long-term outcomes. Although …

CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma

J Li, ZQ Hu, SY Yu, L Mao, ZJ Zhou, PC Wang, Y Gong… - Cancer Research, 2022 - AACR
Although circular RNAs (circRNA) are known to modulate tumor initiation and progression,
their role in hepatocellular carcinoma (HCC) metastasis remains poorly understood. Here …

The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure

JJ Ryan, SL Archer - Circulation research, 2014 - Am Heart Assoc
The right ventricle (RV) is the major determinant of functional state and prognosis in
pulmonary arterial hypertension. RV hypertrophy (RVH) triggered by pressure overload is …

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF

D Bode, L Semmler, P Wakula, N Hegemann… - Cardiovascular …, 2021 - Springer
Background Sodium–glucose linked transporter type 2 (SGLT-2) inhibition has been shown
to reduce cardiovascular mortality in heart failure independently of glycemic control and …

Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

R Savai, HM Al-Tamari, D Sedding, B Kojonazarov… - Nature medicine, 2014 - nature.com
Pulmonary hypertension (PH) is characterized by increased proliferation and apoptosis
resistance of pulmonary artery smooth muscle cells (PASMCs). Forkhead box O (FoxO) …

Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications

X Wang, X Shen, Y Yan, H Li - Bioscience Reports, 2021 - portlandpress.com
Pyruvate dehydrogenase kinase (PDK) can regulate the catalytic activity of pyruvate
decarboxylation oxidation via the mitochondrial pyruvate dehydrogenase complex, and it …

Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension

EL Brittain, M Talati, JP Fessel, H Zhu, N Penner… - Circulation, 2016 - Am Heart Assoc
Background—The mechanisms of right ventricular (RV) failure in pulmonary arterial
hypertension (PAH) are poorly understood. Abnormalities in fatty acid (FA) metabolism have …

Right ventricular adaptation and failure in pulmonary arterial hypertension

JJ Ryan, J Huston, S Kutty, ND Hatton… - Canadian Journal of …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is an obstructive pulmonary vasculopathy,
characterized by excess proliferation, apoptosis resistance, inflammation, fibrosis, and …

Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in …

L Tian, D Wu, A Dasgupta, KH Chen… - Circulation …, 2020 - Am Heart Assoc
Rationale: Right ventricular (RV) fibrosis in pulmonary arterial hypertension contributes to
RV failure. While RV fibrosis reflects changes in the function of resident RV fibroblasts …